Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative).

PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016.

2.

Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.

Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, Van den Hof S.

PLoS One. 2016 May 24;11(5):e0156471. doi: 10.1371/journal.pone.0156471. eCollection 2016.

3.

The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-Analysis.

van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S.

PLoS One. 2016 Apr 28;11(4):e0154095. doi: 10.1371/journal.pone.0154095. eCollection 2016.

4.

Cost-effectiveness of the Xpert(®) MTB/RIF assay for tuberculosis diagnosis in Brazil.

Pinto M, Steffen RE, Cobelens F, van den Hof S, Entringer A, Trajman A.

Int J Tuberc Lung Dis. 2016 May;20(5):611-8. doi: 10.5588/ijtld.15.0455.

PMID:
27084814
5.

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.

Erkens CG, Slump E, Verhagen M, Schimmel H, de Vries G, Cobelens F, van den Hof S.

Eur Respir J. 2016 May;47(5):1492-501. doi: 10.1183/13993003.01397-2015. Epub 2016 Feb 25.

PMID:
26917614
6.

No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.

Cobelens F, Gebhard A, van den Hof S.

Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628. No abstract available.

PMID:
26792486
7.

Using existing data to illustrate--and close--the gap in access to new anti-tuberculosis drugs.

Mitnick C, van den Hof S.

Int J Tuberc Lung Dis. 2016 Feb;20(2):145. doi: 10.5588/ijtld.15.0911. No abstract available.

PMID:
26792461
8.

Elevated mortality after successful tuberculosis treatment.

van den Hof S, Borgdorff MW.

Int J Tuberc Lung Dis. 2016 Jan;20(1):2. doi: 10.5588/ijtld.15.0652. No abstract available.

9.

Correction: Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial.

Durovni B, Saraceni V, van den Hof S, Trajman A, Cordeiro-Santos M, Cavalcante S, Menezes A, Cobelens F.

PLoS Med. 2015 Dec 3;12(12):e1001928. doi: 10.1371/journal.pmed.1001928. eCollection 2015 Dec. No abstract available.

10.

Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

van Kampen SC, Tursynbayeva A, Koptleuova A, Murzakhmetova Z, Bigalieva L, Aubakirova M, Pak S, van den Hof S.

PLoS One. 2015 Aug 19;10(8):e0136368. doi: 10.1371/journal.pone.0136368. eCollection 2015. No abstract available.

11.

Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

van Kampen SC, Tursynbayeva A, Koptleuova A, Murzakhmetova Z, Bigalieva L, Aubakirova M, Pak S, van den Hof S.

PLoS One. 2015 Jul 16;10(7):e0132514. doi: 10.1371/journal.pone.0132514. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0136368. Murzabekova, Zauresh [corrected to Murzakhmetova, Zauresh].

12.

How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

Gebhard A, van den Hof S, Cobelens F.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):117. doi: 10.1164/rccm.201503-0517LE. No abstract available.

PMID:
26131997
13.

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Sachdeva KS, Raizada N, Sreenivas A, Van't Hoog AH, van den Hof S, Dewan PK, Thakur R, Gupta RS, Kulsange S, Vadera B, Babre A, Gray C, Parmar M, Ghedia M, Ramachandran R, Alavadi U, Arinaminpathy N, Denkinger C, Boehme C, Paramasivan CN.

PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065. eCollection 2015.

14.

Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.

Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, Van den Hof S.

PLoS One. 2015 Apr 27;10(4):e0123252. doi: 10.1371/journal.pone.0123252. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0156471.

15.

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.

van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, van Soolingen D, Boeree MJ, van der Werf TS.

Int J Tuberc Lung Dis. 2015 Apr;19(4):406-12. doi: 10.5588/ijtld.14.0838.

PMID:
25859995
16.

HIV and multidrug-resistant tuberculosis: overlapping risk factors.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Ismailov S.

Eur Respir J. 2015 Feb;45(2):567-9. doi: 10.1183/09031936.00131014. No abstract available.

17.

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.

Durovni B, Saraceni V, van den Hof S, Trajman A, Cordeiro-Santos M, Cavalcante S, Menezes A, Cobelens F.

PLoS Med. 2014 Dec 9;11(12):e1001766. doi: 10.1371/journal.pmed.1001766. eCollection 2014 Dec. Erratum in: PLoS Med. 2015 Dec;12(12):e1001928.

18.

High positive predictive value of Xpert in a low rifampicin resistance prevalence setting.

Trajman A, Durovni B, Saraceni V, Cordeiro-Santos M, Cobelens F, van den Hof S.

Eur Respir J. 2014 Dec;44(6):1711-3. doi: 10.1183/09031936.00115514. Epub 2014 Sep 3. No abstract available.

19.

Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil.

Durovni B, Saraceni V, Cordeiro-Santos M, Cavalcante S, Soares E, Louren├žo C, Menezes A, van den Hof S, Cobelens F, Trajman A.

Bull World Health Organ. 2014 Aug 1;92(8):613-7. doi: 10.2471/BLT.13.131409. Epub 2014 May 1.

20.

The epidemiology of childhood tuberculosis in the Netherlands: still room for prevention.

Erkens CG, de Vries G, Keizer ST, Slump E, van den Hof S.

BMC Infect Dis. 2014 May 31;14:295. doi: 10.1186/1471-2334-14-295.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk